These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11379318)

  • 21. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.
    Menchén L; Colón AL; Madrigal JL; Beltrán L; Botella S; Lizasoain I; Leza JC; Moro MA; Menchén P; Cos E; Lorenzo P
    Am J Gastroenterol; 2004 Sep; 99(9):1756-64. PubMed ID: 15330915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
    Selby WS; Janossy G; Mason DY; Jewell DP
    Clin Exp Immunol; 1983 Sep; 53(3):614-8. PubMed ID: 6577996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis.
    Rachmilewitz D; Eliakim R; Ackerman Z; Karmeli F
    Am J Gastroenterol; 1998 Mar; 93(3):409-12. PubMed ID: 9517649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
    Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
    Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis.
    Jankowski JA; Bedford FK; Boulton RA; Cruickshank N; Hall C; Elder J; Allan R; Forbes A; Kim YS; Wright NA; Sanders DS
    Lab Invest; 1998 Sep; 78(9):1155-67. PubMed ID: 9759659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.
    Dijkstra G; Moshage H; van Dullemen HM; de Jager-Krikken A; Tiebosch AT; Kleibeuker JH; Jansen PL; van Goor H
    J Pathol; 1998 Dec; 186(4):416-21. PubMed ID: 10209492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury.
    Beck PL; Xavier R; Wong J; Ezedi I; Mashimo H; Mizoguchi A; Mizoguchi E; Bhan AK; Podolsky DK
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G137-47. PubMed ID: 14665440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide pathway-related gene alterations in inflammatory bowel disease.
    Gillberg L; Varsanyi M; Sjöström M; Lördal M; Lindholm J; Hellström PM
    Scand J Gastroenterol; 2012 Nov; 47(11):1283-97. PubMed ID: 22900953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
    Griga T; Hebler U; Voigt E; Tromm A; May B
    Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease.
    Guihot G; Guimbaud R; Bertrand V; Narcy-Lambare B; Couturier D; Duée PH; Chaussade S; Blachier F
    Amino Acids; 2000; 18(3):229-37. PubMed ID: 10901620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment.
    Leonard N; Bishop AE; Polak JM; Talbot IC
    J Clin Pathol; 1998 Oct; 51(10):750-3. PubMed ID: 10023337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis.
    Vento P; Kiviluoto T; Järvinen HJ; Soinila S
    Scand J Gastroenterol; 2001 Feb; 36(2):180-9. PubMed ID: 11252411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal enhanced gastritis and macrophage microaggregates in the gastric mucosa: potential role in the differential diagnosis between Crohn's disease and ulcerative colitis.
    Magalhães-Costa MH; Reis BR; Chagas VL; Nunes T; Souza HS; Zaltman C
    Arq Gastroenterol; 2014; 51(4):276-82. PubMed ID: 25591154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.
    Murch SH; Braegger CP; Sessa WC; MacDonald TT
    Lancet; 1992 Feb; 339(8790):381-5. PubMed ID: 1346658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ generation of nitric oxide by myenteric neurons but not by mononuclear cells of the human colon.
    Tomobuchi M; Oshitani N; Matsumoto T; Kitano A; Seki S; Arakawa T
    Clin Exp Pharmacol Physiol; 2001; 28(1-2):13-8. PubMed ID: 11153529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.